Biopharmaceutics Classification System: An Industrial Experience
Dr. O. Helen Chan 's remarks on the potential barriers to oral bioavailability in formulations at a Hong Kong symposium; she addresses the bioequivalency of pregabalin and the stability of gabapentin.